维普中文期刊产品整合服务
166篇 您的检索式:作者名="Odunsi"
    题名 作者 年代 出处 被引量
1Pelvic exenterations for gynecological malignancies:twenty-year experience at Ro- swell Park Cancer Institute显示文摘Sharma S Odunsi K Driscoll D 2005Int J Gynecol Cancer2005,15,3:1
2Role of the tumour necrosis family ligand April in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas显示文摘Mhawech-Fauceglia P Allal A Odunsi K 2008Eur J Cancer2008,44,15:1
3High cumulative doses of pegylated liposomal doxombicin are not associated with cardiac toxicity in patients with gynecologic malignancies显示文摘KESTERSON JP ODUNSI K LELE S 2010Chemothera- py2010,56,2:1
4Intraepithelial CDS+ tumor-infiltrating lymphocytes and a high CD8+/regnlatory T cell ratio are associated with favorable prognosis in ovarian cancer显示文摘Sato E Olson SH Ahn J Bundy B Nishikawa H Qian F Jungbluth AA Frosina D Gnjatic S Ambrosone C Kepner J Odunsi T Ritter G Lele S Chen YT Ohtani H Old LJ Odunsi K 2005Proc Natl Acad Sci USA2005,102,18:1
5NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epi- thelial ovarian cancer显示文摘Odunsi K J ungbluth AA Stockert E 2003Cancer Res2003,63,18:1
6Generation and regulation of human CD4+IL-17-producing T cells in ovarian cancer显示文摘Miyahara Y Odunsi K Chen W 2008Proc Natl Acad Sci U S A2008,105,15:1
7Generation and regulation of human CD4 IL-17-producing T cells in ovarian cancer 显示文摘Miyahara Y Odunsi K Chen W 2008Proc Natl Acad Sci USA2008,105,15:1
8原发性免疫缺陷病患者肿瘤发生情况:美国免疫缺陷网络注册患者肿瘤发病率分析显示文摘研究背景评估了在美国免疫缺陷网络(USIDNET)注册的原发性免疫缺陷病(PIDDs)患者的总体和器官特异性肿瘤发病率,并与监测、流行病学和最终结果项目(SEER)数据库中经年龄校正的人群的肿瘤发病率进行比较。目的假设PIDD患者由于免疫功能受损,肿瘤发病率会增加。方法将2003年至2015年在USIDNET注册中心注册的PIDD (n=3658)患者的总体和器官特异性肿瘤发病率进行评估,并与SEER数据库中经年龄校正的人群发病率进行比较。结果与年龄相匹配的SEER人群相比,观察到PIDD患者罹患肿瘤的相对危险率为1. 42倍(P<0. 001)。PIDD的男性患癌症的风险是年龄校正的男性人群的1. 91倍(P<0. 001),而PIDD女性患者的总体肿瘤发病率与经年龄校正的女性人群相比并无差异。对SEER数据库中最常见的4个恶性肿瘤——肺癌、结肠癌、乳腺癌和前列腺癌的发病率进行分析,PIDD患者中这些肿瘤的发病没有显著增加。男性和女性PIDD患者的淋巴瘤发病率均显著增加(男性10倍,P<0. 001;女性8. 34倍,P<0. 001)。结论 PIDD患者的肿瘤发病率较高。在特定的PIDD人群中淋巴瘤发病率的增高是导致总体肿瘤发病率提高的主要原因,而常见的实体肿瘤的风险没有增加。这些数据表明免疫系统在预防特定肿瘤方面有一定的作用。Paul C.Mayor Kevin H.Eng Kelly L.Singel Scott I.Abrams Kunle Odunsi Kirsten B.Moysich Ramsay Fuleihan Elizabeth Garabedian Patricia Lugar Hans D.Ochs Francisco A.Bonilla Rebecca H.Buckley Kathleen E.Sullivan Zuhair K.Ballas Charlotte Cunningham-Rundles Brahm H.Segal 白炜 曾小峰 2018中华临床免疫和变态反应杂志2018,12,2:1
9Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer显示文摘Miyahara Y Odunsi K Chert W 2008Proc Natl Acad Sci U S A2008,105,15:1
10Generation and regulation of human CD4+IL-17-producing T cells in ovarian cancer显示文摘Miyahara Y Odunsi K Chen W 2008Proc Natl Acad Sci U S A2008,105,15:1
11Generation and regulation of human CD+4IL-17-produeing T cells in ovarian caneer显示文摘Miyahara Y Odunsi K Chen W 2008Proc Natl Aead Sci USA2008,105,15:1
12Generation and regulation of human CD4~ IL-17-producing T cells in ovarian cancer显示文摘MIYAHARA Y ODUNSI K CHEN W 2008Proc Natl Aead Sei USA2008,105,15:1
13Generation and reguhtion of human CD4+ IL-17-producing T cells in ovarian cancer显示文摘Miyahara Y Odunsi K Chen W 0,,:1
14T Cell Assays and MIATA: The Essential Minimum for Maximum Impact显示文摘C.M. Britten S. Janetzki L.H. Butterfield G. Ferrari C. Gouttefangeas C. Huber M. Kalos H.I. Levitsky H.T. Maecker C.J.M. Melief J. O’Donnell-Tormey K. Odunsi L.J. Old T.H.M. Ottenhoff C. Ottensmeier G. Pawelec M. Roederer B.O. Roep P. Romero S.H. van der 2012Immunity2012,,1:1
15Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer显示文摘Odunsi K Matsuzaki J James SR 2014Cancer Im- munol Res2014,2,1:1
16TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas显示文摘Brandon-Luke L. Seagle Chia-Ping Huang Yang Kevin H. Eng Monica Dandapani Oluwatosin Odunsi-Akanji Gary L. Goldberg Kunle Odunsi Susan Band Horwitz Shohreh Shahabi 2015Gynecologic Oncology2015,,:1
17PGE (2)- induced CXCLI2 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer enviro- nment 显示文摘Obermajer N Muthuswamy R Odunsi K 2011Cancer Res2011,71,24:1
18NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer显示文摘Odunsi K Jungbluth AA Stockert E 2003Cancer Res2003,63,18:1
19Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium显示文摘Cedrik Michael Britten Sylvia Janetzki Leah Ben-Porat Timothy M. Clay Michael Kalos Holden Maecker Kunle Odunsi Michael Pride Lloyd Old Axel Hoos Pedro Romero 2009Cancer Immunology Immunotherapy2009,,10:1
20Effect of alginate on satiation,appetite,gastric function,and selected gut satiety hormones in overweight and obesity显示文摘Odunsi ST Vazquez-Roque MI Camilleri M 2010Obesity(Silver Spring)2010,18,8:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费